(Q41435811)

30 September 2017

title

Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270. (English)

1 reference

30 September 2017

15

0 references

author name string

Zhizhen Qi

1

1 reference

30 September 2017

Lei Zhou

2

1 reference

30 September 2017

Qingwen Zhang

3

1 reference

30 September 2017

Lingling Ren

4

1 reference

30 September 2017

Ruixia Dai

5

1 reference

30 September 2017

Benchuan Wu

6

1 reference

30 September 2017

Tang Wang

7

1 reference

30 September 2017

Ziwen Zhu

8

1 reference

30 September 2017

Yonghai Yang

9

1 reference

30 September 2017

Baizhong Cui

10

1 reference

30 September 2017

Zuyun Wang

11

1 reference

30 September 2017

Hu Wang

12

1 reference

30 September 2017

Yefeng Qiu

13

1 reference

30 September 2017

Zhaobiao Guo

14

1 reference

30 September 2017

Ruifu Yang

15

1 reference

30 September 2017

Xiaoyi Wang

16

1 reference

30 September 2017

language of work or name

English

0 references

publication date

9 March 2009

1 reference

30 September 2017

1 reference

30 September 2017

volume

28

1 reference

30 September 2017

issue

6

1 reference

30 September 2017

page(s)

1655-1660

1 reference

Yersinia pestis--etiologic agent of plague

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Plague: from natural disease to bioterrorism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Yersinia pestis (plague) vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

A single dose sub-unit vaccine protects against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Protective efficacy of a fully recombinant plague vaccine in the guinea pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Current challenges in the development of vaccines for pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Immune defense against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

LcrV plague vaccine with altered immunomodulatory properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Development of novel drug delivery system (DDS) technologies for proteomic-based drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Translating innate immunity into immunological memory: implications for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

The effectiveness and limitations of immune memory: understanding protective immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Mini-review CD4 T cells are required for CD8 T cell memory generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Cell-mediated protection against pulmonary Yersinia pestis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Immunization of mice with YscF provides protection from Yersinia pestis infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Human immune response to a plague vaccine comprising recombinant F1 and V antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

inferred from DOI database lookup

7 January 2021

based on heuristic

Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.078

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.02.078

1 reference

30 September 2017

1 reference